The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback